A detailed history of Lecap Asset Management LTD transactions in Exelixis, Inc. stock. As of the latest transaction made, Lecap Asset Management LTD holds 12,553 shares of EXEL stock, worth $424,542. This represents 0.07% of its overall portfolio holdings.

Number of Shares
12,553
Holding current value
$424,542
% of portfolio
0.07%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

BUY
$21.96 - $27.6 $275,663 - $346,462
12,553 New
12,553 $326 Million
Q4 2023

Jan 29, 2024

BUY
$19.25 - $24.13 $164,568 - $206,287
8,549 New
8,549 $205 Million

Others Institutions Holding EXEL

About EXELIXIS, INC.


  • Ticker EXEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 321,832,000
  • Market Cap $10.9B
  • Description
  • Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...
More about EXEL
Track This Portfolio

Track Lecap Asset Management LTD Portfolio

Follow Lecap Asset Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lecap Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Lecap Asset Management LTD with notifications on news.